Oculis Holding AG (Oculis Holding AG) YoY EBITDA Growth : 86.89% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Oculis Holding AG's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 86.89%.

Oculis Holding AG's EBITDA per Share for the three months ended in Mar. 2024 was $-0.49.

Oculis Holding AG YoY EBITDA Growth Historical Data

The historical data trend for Oculis Holding AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG YoY EBITDA Growth Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-6.59

-139.36

-221.99

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial							-2,752.67	-25.45	-112.30	-53.13	86.89

Oculis Holding AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Oculis Holding AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-3.368	-	-1.046)	/	\| -1.046 \|
=	-221.99 %

Oculis Holding AG's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.49	-	-3.737)	/	\| -3.737 \|
=	86.89 %

Oculis Holding AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (Oculis Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.